<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04653298</url>
  </required_header>
  <id_info>
    <org_study_id>7951</org_study_id>
    <nct_id>NCT04653298</nct_id>
  </id_info>
  <brief_title>Health-related Quality of Life in Adults After Veno-arterial Extra-Corporeal Membrane Oxygenation Which is a Salvage Therapy Used in Patients With Severe Respiratory or Cardiac Failure Who Have Not Responded to Maximal Conventional Medical Therapy</brief_title>
  <official_title>Health-related Quality of Life in Adults After Veno-arterial Extra-Corporeal Membrane Oxygenation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Extracorporeal Membrane Oxygenation (ECMO) is a salvage therapy used in patients with&#xD;
      refractory cardiogenic shock. This rescue technique is associated to a high mortality rate&#xD;
      and to many complications that can impact the quality of life of the survivors. The aim of&#xD;
      this study is to evaluate the Health-related quality of life in adults after veino-arterial&#xD;
      Extra-Corporeal Membrane Oxygenation. The quality of life will be evaluated thanks to several&#xD;
      methods : the Short Form 36, the EQ 5D 5L and the return to work status.&#xD;
&#xD;
      Then, the investigators will analyze by subgroup the quality of life according to the&#xD;
      cardiogenic shock etiology and try to determine the risk factors of an altered quality of&#xD;
      life. The investigators will also evaluate current comorbidities of the patient thanks to the&#xD;
      Groll Index.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Actual">December 21, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of health-related quality of life after veino-arterial ECMO</measure>
    <time_frame>The quality of life will be evaluated from 1 to 12 years after the ECMO</time_frame>
    <description>Quality of life will be evaluated by Short Form 36 ( score 0 to 100)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of health-related quality of life after veino-arterial ECMO</measure>
    <time_frame>The quality of life will be evaluated from 1 to 12 years after the ECMO</time_frame>
    <description>EQ 5D 5L ( description of mobility, personal autonomy, routine activities, pain and discomfort, anxiety and depression and an analog visual scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis by subgroup according to the cardiogenic shock etiology</measure>
    <time_frame>The quality of life will be evaluated from 1 to 12 years after the ECMO</time_frame>
    <description>5 subgroups will be assessed according to the cardiogenic shock etiology: post cardiac surgery, post cardiac ischemia, pulmonary embolism or other right ventricle dysfunction, other etiology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Research of risk factors of an altered quality of life</measure>
    <time_frame>The quality of life will be evaluated from 1 to 12 years after the ECMO</time_frame>
    <description>5 subgroups will be assessed according to the cardiogenic shock etiology: post cardiac surgery, post cardiac ischemia, pulmonary embolism or other right ventricle dysfunction, other etiology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the current comorbidities thanks to Groll index</measure>
    <time_frame>The quality of life will be evaluated from 1 to 12 years after the ECMO</time_frame>
    <description>5 subgroups will be assessed according to the cardiogenic shock etiology: post cardiac surgery, post cardiac ischemia, pulmonary embolism or other right ventricle dysfunction, other etiology</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Veno-arterial Extra-Corporeal Membrane Oxygenation</condition>
  <condition>Health Related Quality of Life</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evaluation of quality of life, comorbidities and return to work status</intervention_name>
    <description>Quality of life will be evaluated thanks to several methods: Short Form 36, EQ 5D 5L and return to work status Questionnaires will be evaluated through postal and phone call at least 12 months after ECMO.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with veno-arterial ECMO between April 2008 and December 2019 in NHC surgical&#xD;
        intensive care of Strasbourg are included in this study. Those patients are retrieved&#xD;
        thanks to the Software ICCA.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults &gt;18 years&#xD;
&#xD;
          -  Veno-arterial ECMO between April 2008 and December 2019 in NHC surgical intensive care&#xD;
             of Strasbourg&#xD;
&#xD;
          -  Affiliated to the French social security system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Patients under guardianship or with legal protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Les HÃ´pitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lina JAZERLI</last_name>
      <phone>+33 3 69 55 16 22</phone>
      <email>lina.jazaerli@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Lina JAZERLI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier COLLANGE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul-Michel MERTES</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 28, 2020</study_first_submitted>
  <study_first_submitted_qc>December 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2020</study_first_posted>
  <last_update_submitted>March 29, 2021</last_update_submitted>
  <last_update_submitted_qc>March 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

